Literature DB >> 20065612

Chronic kidney disease, all-cause mortality and cardiovascular mortality among Chinese patients with established cardiovascular disease.

Jin-gang Yang1, Jue Li, Changlin Lu, Buaijiaer Hasimu, Yuejin Yang, Dayi Hu.   

Abstract

AIM: This study was conducted to investigate the role of chronic kidney disease (CKD) in 1-year all cause mortality and cardiovascular mortality among Chinese patients who were at least 50 years old and had a history of coronary artery disease (CAD), stroke, or peripheral vascular disease (PAD), or with two or more cardiovascular risks.
METHODS: Of 3,732 hospitalized patients enrolled, 3,423 patients (91.7%) with complete data were eligible for 1-year follow-up. CKD was defined as an estimated glomerular filtration rate (eGFR) of <60 mL/min/1.73 m(2).
RESULTS: 1,166 (34.1%) were diagnosed with CKD. Most cases were unrecognized. Patients having an eGFR of <30 mL/min/1.73 m(2) were less likely to be prescribed beta-blockers, statins, or aspirin (all p<0.001). A powerful relationship was observed between the severity of renal dysfunction and all causes of death or cardiovascular death. Adjusted for other covariates, the hazard ratio (HR) for all causes of death and for cardiovascular death among patients with an eGFR of 30-45 mL/min/1.73 m(2) was 1.70 (95% CI, 1.18-2.45) and 1.85 (95% CI, 1.12-3.01) as compared with 2.93 (95% CI, 1.96-4.38) and 3.47 (95% CI, 1.91-6.31) for patients with an eGFR of <30 mL/min/1.73 m(2).
CONCLUSIONS: One third of Chinese patients at high risk for atherosclerotic events were diagnosed with CKD. Most of these cases were unrecognized and undertreated. An eGFR of <45 mL/min/1.73 m(2) was an independent predictor of all causes of death and of cardiovascular death.

Entities:  

Mesh:

Year:  2010        PMID: 20065612     DOI: 10.5551/jat.3061

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  7 in total

1.  Vascular disease, ESRD, and death: interpreting competing risk analyses.

Authors:  Morgan E Grams; Josef Coresh; Dorry L Segev; Lauren M Kucirka; Hocine Tighiouart; Mark J Sarnak
Journal:  Clin J Am Soc Nephrol       Date:  2012-08-02       Impact factor: 8.237

2.  Chapter 4: Other complications of CKD: CVD, medication dosage, patient safety, infections, hospitalizations, and caveats for investigating complications of CKD.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2013-01

3.  Chapter 5: Referral to specialists and models of care.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2013-01

4.  Estimated Glomerular Filtration Rate and Mortality among Patients with Coronary Heart Disease.

Authors:  Qian Chen; Yuan Zhang; Ding Ding; Min Xia; Dan Li; Yunou Yang; Qing Li; Jiaxing Liu; Xuechen Chen; Gang Hu; Wenhua Ling
Journal:  PLoS One       Date:  2016-08-18       Impact factor: 3.240

5.  Chronic Kidney Disease And Associated Risk Factors Among Cardiovascular Patients.

Authors:  Getahun Chala; Tariku Sisay; Yonas Teshome
Journal:  Int J Nephrol Renovasc Dis       Date:  2019-09-18

6.  The association between atherosclerotic renal artery stenosis and acute kidney injury in patients undergoing cardiac surgery.

Authors:  Jingang Yang; Changlin Lu; Li Yan; Xinran Tang; Wei Li; Yuejin Yang; Dayi Hu
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

7.  Uremic toxin indoxyl sulfate promotes proinflammatory macrophage activation by regulation of β-catenin and YAP pathways.

Authors:  Ying Li; Jing Yan; Minjia Wang; Jing Lv; Fei Yan; Jin Chen
Journal:  J Mol Histol       Date:  2021-01-02       Impact factor: 2.611

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.